We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
246 hedge funds and large institutions have $2.96B invested in Iovance Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 95 increasing their positions, 85 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
333% more call options, than puts
Call options by funds: $76.2M | Put options by funds: $17.6M
18% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 34
12% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 85
1% more funds holding
Funds holding: 243 → 246 (+3)
2.55% less ownership
Funds ownership: 101.91% → 99.36% (-2.5%)
24% less capital invested
Capital invested by funds: $3.88B → $2.96B (-$921M)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Holders
246
Holders Change
+3
Holders Change %
+1.23%
% of All Funds
3.79%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.05%
New
40
Increased
95
Reduced
85
Closed
34
Calls
$76.2M
Puts
$17.6M
Net Calls
+$58.6M
Net Calls Change
+$39M
